human
metapneumoviru
hmpv
respiratori
pathogen
discov
consid
major
caus
upper
lower
respiratori
tract
infect
sensit
fast
highthroughput
diagnost
test
need
detect
hmpv
may
assist
clinic
manag
well
reduct
inappropri
therapi
therefor
comparison
assess
perform
studi
genesig
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
assay
infin
respiratori
viral
panel
plu
assay
rvpplu
detect
hmpv
infect
patient
respiratori
tract
infect
total
respiratori
sampl
collect
hospit
patient
winter
season
kuwait
patient
posit
hmpv
rna
inhous
rtpcr
assay
posit
hmpv
rna
realtim
rtpcr
assay
posit
hmpv
rna
infin
rvpplu
assay
high
incid
rate
hmpv
infect
januari
sensit
realtim
rtpcr
infin
rvpplu
assay
respect
specif
assay
hmpv
type
b
could
identifi
studi
howev
discord
genotyp
result
found
direct
sequenc
method
infin
rvpplu
assay
hmpvposit
patient
common
caus
respiratori
tract
infect
virus
although
etiolog
agent
viral
respiratori
infect
identifi
half
case
dong
et
al
snell
nucleic
acid
amplif
test
gold
standard
approach
diagnosi
viral
respiratori
infect
lee
et
al
compar
old
convent
approach
cultur
method
spite
difficulti
diagnosi
wide
rang
viral
respiratori
infect
due
similar
clinic
present
symptom
sign
nucleic
acid
amplif
test
assist
process
fox
recent
nucleic
acid
amplif
test
polymeras
chain
reaction
method
pcr
revers
transcriptionpolymeras
chain
reaction
rtpcr
realtim
pcr
multiplex
pcr
combin
microarray
detect
use
wide
diagnosi
respiratori
virus
enhanc
sensit
specif
convent
method
human
metapneumoviru
hmpv
first
identifi
van
den
hoogen
et
al
nasopharyng
aspir
children
respiratori
tract
infect
netherland
sinc
implic
common
caus
upper
lower
respiratori
tract
infect
children
adult
age
boivin
et
al
hmpv
singl
negativestrand
rna
envelop
viru
classifi
pneumovirina
subfamili
paramyxovirida
famili
genet
analysi
reveal
rel
high
degre
sequenc
variabl
differ
hmpv
isol
major
subgroup
b
identifi
subsequ
genet
analysi
led
subdivis
hmpv
b
subgroup
subtyp
biacchesi
et
al
moreov
subgroup
subdivid
minor
subgroup
huck
et
al
hmpv
infect
season
peak
infect
winter
spring
month
ali
et
al
alturab
et
al
sugru
et
al
previous
publish
data
shown
preval
hmpv
infect
hospit
patient
respiratori
symptom
preval
among
infant
elderli
patient
pneumonia
alturab
et
al
result
emphas
need
establish
rapid
sensit
assay
detect
hmpv
clinic
sampl
recent
commerci
multiplex
pcr
assay
base
microarray
technolog
simultan
detect
panel
respiratori
virus
introduc
market
howev
multiplex
approach
may
compromis
abil
assay
detect
low
viral
load
therefor
studi
aim
compar
sensit
multiplex
pcr
assay
infin
respiratori
viral
panel
plu
assay
rvpplu
autogenom
california
usa
inhous
rtpcr
commerci
realtim
rtpcr
assay
genesig
primerdesign
ltd
southampton
hant
uk
standard
hmpv
rna
use
assay
posit
control
total
respiratori
sampl
collect
hospit
patient
mubarak
alkabir
hospit
either
upper
lower
respiratori
tract
infect
winter
season
state
kuwait
decemb
till
februari
ninetyseven
male
femal
age
group
day
year
differ
nation
total
number
patient
intens
care
unit
differ
hospit
ward
patient
infant
less
year
children
year
adult
year
elderli
patient
year
old
respiratori
sampl
includ
nasopharyng
swab
endotrach
tube
secret
tracheal
aspir
bronchoalveolar
lavag
throat
swab
nasal
swab
nasopharyng
aspir
total
number
respiratori
sampl
receiv
decemb
januari
februari
respect
respiratori
sampl
collect
obtain
written
inform
consent
patient
ethic
permiss
research
studi
grant
ethic
decis
committe
research
administr
faculti
medicin
kuwait
univers
hmpv
rna
extract
respiratori
specimen
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
rna
elut
buffer
provid
kit
store
process
set
degener
primer
select
basi
sequenc
previous
publish
mackay
et
al
forward
primer
hmpvf
nucleotid
posit
revers
primer
hmpvr
nucleotid
posit
amplifi
n
gene
hmpv
isol
genbank
access
number
rtpcr
perform
use
qiagen
onestep
rtpcr
kit
qiagen
previous
describ
alturab
et
al
hmpv
rna
detect
use
commerci
genesig
realtim
rtpcr
assay
hmpv
detect
quantif
use
primer
amplifi
hmpv
nucleoprotein
gene
ten
microlit
onestep
q
rtpcr
mastermix
primer
design
ad
hmpvspecif
primerprob
mix
nucleasefre
water
extract
rna
sampl
appli
biosystem
fast
realtim
pcr
system
appli
biosystem
foster
citi
ca
usa
use
hmpv
detect
quantif
accord
follow
cycl
first
min
second
min
third
cycl
accord
manufactur
instruct
genesig
realtim
rtpcr
quantif
kit
design
detect
quantif
hmpv
subtyp
optim
pcr
condit
assay
detect
copi
target
templat
infin
respiratori
viru
panel
plu
rvpplu
assay
autom
analyz
autogenom
design
detect
common
respiratori
virus
includ
subtyp
influenza
swine
b
human
parainfluenza
viru
rhinoviru
b
enteroviru
b
c
coronaviru
hmpv
b
human
respiratori
syncyti
viru
b
adenoviru
b
c
e
firststrand
cdna
synthesi
perform
use
superscript
iii
rt
supermix
invitrogen
california
usa
pcr
master
mix
prepar
ad
rvp
plu
amplif
mix
autogenom
platinum
taq
polymeras
invitrogen
pcr
mix
gentli
mix
dispens
well
plate
templat
cdna
ad
appropri
well
pcr
condit
follow
min
cycl
min
min
min
amplif
product
clean
enzymat
reaction
subject
primer
extens
analyz
autogenom
indic
manufactur
instruct
sampl
consid
posit
ratio
signal
viru
background
signal
greater
threshold
predetermin
manufactur
softwar
pcr
product
obtain
inhous
rtpcr
assay
purifi
directli
sequenc
use
abi
terminatorcycl
sequenc
v
readi
reaction
kit
appli
biosystem
use
hmpvf
hmpvr
primer
describ
earlier
alturab
et
al
signific
differ
categor
variabl
among
variou
group
patient
test
use
test
fisher
exact
test
appropri
statist
analysi
perform
use
spss
softwar
v
spss
chicago
il
usa
patient
involv
studi
either
upper
lower
respiratori
tract
infect
among
patient
lower
respiratori
tract
infect
pneumonia
respiratori
distress
bronchiol
bronchial
asthma
chronic
obstruct
pulmonari
diseas
bronchopneumonia
pulmonari
edema
ten
sampl
found
posit
hmpv
rna
inhous
rtpcr
correspond
patient
turnaround
time
test
h
howev
patient
posit
hmpv
rna
genesig
realtim
rtpcr
assay
sensit
total
turnaround
time
h
nine
posit
infin
rvpplu
assay
sensit
turnaround
time
h
specif
assay
realtim
rtpcr
infin
rvpplu
incid
hmpv
infect
high
januari
n
februari
n
low
decemb
n
genotyp
hmpv
rna
detect
infin
rvpplu
assay
compar
detect
direct
sequenc
concord
result
obtain
sampl
tabl
comparison
differ
molecular
assay
detect
genotyp
hmpv
rna
term
cost
turnaround
time
autom
shown
tabl
hmpv
rnaposit
patient
pneumonia
n
respiratori
distress
upper
respiratori
tract
infect
overal
proport
hmpv
infect
femal
n
male
n
p
sixti
percent
hmpvposit
patient
infant
less
year
children
year
adult
year
hmpv
detect
among
elderli
patient
year
moreov
hmpvposit
patient
admit
intens
care
unit
hospit
ward
hmpv
detect
follow
type
respiratori
sampl
nasopharyng
detect
hmpv
molecular
method
prefer
convent
method
sinc
viru
replic
poorli
convent
cell
cultur
van
den
hoogen
et
al
sensit
rapid
autom
highthroughput
diagnost
test
need
detect
hmpv
respiratori
virus
may
assist
clinic
manag
well
reduct
implement
inappropri
therapi
hospit
barenfang
et
al
fox
recent
studi
suggest
import
compar
molecular
diagnost
method
molecular
techniqu
assess
perform
superior
sensit
molecular
method
compar
convent
one
ali
et
al
therefor
studi
compar
sensit
molecular
assay
genesig
realtim
rtpcr
infin
rvpplu
assay
refer
assay
inhous
rtpcr
use
set
degener
primer
target
n
gene
detect
hmpv
rna
clinic
specimen
inhous
rtpcr
use
gold
standard
test
confirm
presenc
absenc
hmpv
rna
case
discrep
assay
hmpv
rnaposit
sampl
detect
inhous
rtpcr
confirm
direct
sequenc
although
rtpcr
still
method
choic
detect
hmpv
rna
mani
clinic
laboratori
high
sensit
specif
jin
et
al
kroll
weinberg
zhu
et
al
prefer
due
total
turnaround
time
need
along
confirmatori
test
sequenc
may
take
total
h
commerci
realtim
rtpcr
also
target
n
gene
show
lower
sensit
compar
inhous
rtpcr
infin
rvpplu
assay
turnaround
time
accomplish
realtim
rtpcr
h
hmpv
rna
detect
well
quantif
infin
rvpplu
assay
show
higher
sensit
genesig
realtim
rtpcr
specimen
result
posit
intern
control
ensur
valid
result
turnaround
time
detect
genotyp
hmpv
rna
respiratori
virus
use
infin
rvpplu
requir
around
h
sampl
hmpv
rna
could
detect
sampl
infin
rvpplu
assay
also
hardli
detect
realtim
rtpcr
show
low
viral
load
suggest
discord
due
differ
sensit
assay
detect
low
viral
load
report
earlier
ali
et
al
result
indic
hmpv
genotyp
b
circul
predomin
certain
genotyp
howev
infin
rvpplu
assay
show
discrep
genotyp
result
direct
sequenc
method
although
genotyp
requir
viral
infect
case
studi
show
case
hmpv
infect
correl
differ
hmpv
genotyp
sever
outcom
diseas
agapov
et
al
debur
et
al
previou
studi
conduct
compar
microarray
assay
autom
infin
analyz
realtim
pcr
assay
detect
respiratori
virus
shown
assay
abl
detect
panel
respiratori
virus
clinic
specimen
concord
result
specimen
raymond
et
al
recent
sever
data
publish
concern
evalu
differ
molecularbas
techniqu
detect
respiratori
virus
show
discrep
result
differ
molecular
method
ali
et
al
aren
et
al
dare
et
al
gharabaghi
et
al
raymond
et
al
although
multiplex
pcr
combin
microarray
detect
infin
rvpplu
assay
sensit
highthroughput
samplesrun
time
save
expert
techniqu
commonli
use
clinic
laboratori
owe
cost
complex
hmpv
known
common
diseas
young
children
alturab
et
al
falsey
et
al
principi
et
al
william
et
al
van
den
hoogen
et
al
data
shown
hmpvposit
patient
infant
less
year
previou
work
hmpv
infect
detect
among
children
adult
year
year
alturab
et
al
howev
studi
hmpv
detect
children
age
year
adult
age
year
three
age
group
pneumonia
admit
intens
care
unit
emphas
import
hmpv
infect
young
children
elderli
peopl
also
middleag
group
support
find
previou
studi
show
hmpv
infect
occur
adult
age
may
account
signific
portion
person
hospit
respiratori
infect
falsey
et
al
addit
previou
studi
rhinoviru
found
major
caus
acut
respiratori
infect
follow
hmpv
respiratori
syncyti
viru
adenovirus
find
also
obtain
present
studi
data
shown
alturab
et
al
conclus
current
studi
show
import
detect
hmpv
respiratori
pathogen
use
advanc
molecular
assay
microarraybas
assay
higher
sensit
rapid
throughput
compar
molecular
assay
